| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/14/2006 | US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/14/2006 | US20060281698 a single-stranded antisense oligonucleotide, targeted to nucleic acid encoding lipid-free protein constituents of plasma lipoproteins, used for diagnosis and therapy of cardiovascular disorders, including myocardial infarction and atherosclerosis |
| 12/14/2006 | US20060281697 Methods and kits for diagnosing and treating b-cell chronic lymphocytic leukemia |
| 12/14/2006 | US20060281696 Decoy-oligonucleotide-inhibition of cd40-expression |
| 12/14/2006 | US20060281680 Methods and compositions for modulating vascular integrity |
| 12/14/2006 | US20060281679 Human FGF-23 gene and gene expression products |
| 12/14/2006 | US20060281672 Dec-205 (ly 75)/dcl-1 intergenic splice variants associated with hodgkin's disease, and uses thereof |
| 12/14/2006 | US20060281182 Electroporation apparatus and methods |
| 12/14/2006 | US20060281181 Adaptor-directed helper systems |
| 12/14/2006 | US20060281180 Vectors |
| 12/14/2006 | US20060281179 Inducer for differentiation of embryo stem cells into ectodermal cells method of obtaining the same and use thereof |
| 12/14/2006 | US20060281175 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 12/14/2006 | US20060281150 Preparing membrane receptors from extracellular baculoviruses |
| 12/14/2006 | US20060281149 Transforming growth factor-beta-related molecules and uses thereof |
| 12/14/2006 | US20060281148 Cell-free extracts and synthesis of active hydrogenase |
| 12/14/2006 | US20060281147 Thrombin-like recombinant baxtroxobin expressed by pichia sp.and production method thereof |
| 12/14/2006 | US20060281146 Novel compositions and methods for the treatment of immune related diseases |
| 12/14/2006 | US20060281129 Method for detecting biopolymers |
| 12/14/2006 | US20060281128 Compositions and methods using lentivirus-based vectors for generating immune responses |
| 12/14/2006 | US20060281125 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 12/14/2006 | US20060281102 Methods for detecting genetic haplotypes by interaction with probes |
| 12/14/2006 | US20060281095 44 human secreted proteins |
| 12/14/2006 | US20060281090 Capsid-modified adenovirus vectors and methods of using the same |
| 12/14/2006 | US20060281088 Markers for lxr activation |
| 12/14/2006 | US20060281086 Comprising reverse transcription (RT) of mRNA; polymerase chain reaction; highly sensitive ; can be partially or fully automated |
| 12/14/2006 | US20060281082 Genome partitioning |
| 12/14/2006 | US20060281081 Method of diagnosing colon and gastric cancers |
| 12/14/2006 | US20060281080 Novel lipases and uses thereof |
| 12/14/2006 | US20060281079 Preparing a cDNA molecule by contacting an RNA molecule, in the presence of dNTPs, with a non-LTR retrotransposon protein or polypeptide having reverse transcriptase, producing a cDNA molecule complementary to the RNA molecule |
| 12/14/2006 | US20060281078 Human fast-1 gene |
| 12/14/2006 | US20060281073 Comprises a peptide ligand for a cell surface binding site other than coxsackievirus and adenovirus receptor (CAR); higher activity and functionality into the adenovirus gene therapy/gene vaccination system |
| 12/14/2006 | US20060280798 Nanoparticles for delivery of a pharmacologically active agent |
| 12/14/2006 | US20060280758 Modified vaccinia ankara virus variant |
| 12/14/2006 | US20060280757 Flavivirus vaccine delivery system |
| 12/14/2006 | US20060280752 Peptide epitope-based vaccine for treating Herpes Simplex Virus infections and related diseases |
| 12/14/2006 | US20060280751 Method for enhancing efficacy of preparation of monoclonal antibody |
| 12/14/2006 | US20060280750 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity |
| 12/14/2006 | US20060280749 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 12/14/2006 | US20060280747 capable of binding to mouse Vascular endothelial cell growth factor (VEGF) and human VEGF; cancer, diabetes related diseases, edema, inflammation |
| 12/14/2006 | US20060280743 Immunoglobulin for treatment of alzheimer's diseases |
| 12/14/2006 | US20060280741 Administering the antibody concurrently with an antagonist of IL-1 alpha to treat psoriatic arthritis; arthritis nodosa; seronegative spondylarthropathy, and ulcerative colitis |
| 12/14/2006 | US20060280734 Retargeting |
| 12/14/2006 | US20060280728 Trimeric OX40-immunoglobulin fusion protein and methods of use |
| 12/14/2006 | US20060280725 Compositions and methods of treating and diagnosing hepatoma |
| 12/14/2006 | DE10234905B4 Verfahren zur Verbesserung des akustisch induzierten Molekültransfers Method of improving the acoustic-induced molecule transfers |
| 12/14/2006 | DE102005025191A1 Verfahren zum Identifizieren von fungizid wirksamen Verbindungen basierend auf Isopentenylpyrophosphat-Isomerasen A method for identifying fungicidally active compounds based on isopentenyl pyrophosphate isomerases |
| 12/14/2006 | CA2614295A1 Transcription factor decoy |
| 12/14/2006 | CA2611539A1 Insect-specific protease recognition sequences |
| 12/14/2006 | CA2611452A1 Method of manufacturing probe-immobilized carrier |
| 12/14/2006 | CA2611446A1 Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea |
| 12/14/2006 | CA2611445A1 Method for evaluation of compound using rsk1 |
| 12/14/2006 | CA2611409A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis |
| 12/14/2006 | CA2611253A1 Transgenic plants with improved growth characteristics comprising enhanced expression of a leucine rich receptor-like kinase and methods of making the same |
| 12/14/2006 | CA2611092A1 Nucleic acid molecules encoding sucrose synthase-like polypeptides and methods of use |
| 12/14/2006 | CA2610976A1 Use of stefin a as a scaffold protein |
| 12/14/2006 | CA2610709A1 Transgenic models for different genes and their use for gene characterization |
| 12/14/2006 | CA2610405A1 Mannitol induced promoter systems in bacterial host cells |
| 12/14/2006 | CA2609999A1 Stable and soluble antibodies inhibiting tnfalpha |
| 12/14/2006 | CA2608818A1 Method of producing antibodies with modified fucosylation level |
| 12/14/2006 | CA2607841A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 12/14/2006 | CA2604087A1 Lipase polypeptide |
| 12/13/2006 | EP1732021A1 Method of searching specific base sequence |
| 12/13/2006 | EP1731615A1 Cytoplasmic localization dna and rna |
| 12/13/2006 | EP1731614A1 Reversible nuclear genetic system for male sterility in transgenic plants |
| 12/13/2006 | EP1731613A2 Nucleotide sequence for the zwf gene |
| 12/13/2006 | EP1731612A1 Recombinant herpesvirus and utilization of the same |
| 12/13/2006 | EP1731611A2 Eimeria hydrophilic polypeptides as vaccines |
| 12/13/2006 | EP1731610A1 Proteins imparting boron-tolerance and genes thereof |
| 12/13/2006 | EP1731609A1 Rad51 EXPRESSION INHIBITOR, DRUG CONTAINING THE INHIBITOR AS THE ACTIVE INGREDIENT AND UTILIZATION THEREOF |
| 12/13/2006 | EP1731608A1 Marker gene for arthrorheumatism test |
| 12/13/2006 | EP1731607A1 shRNA and siRNA expression in a living organism under control of a codon-optimized tetracycline repressor gene |
| 12/13/2006 | EP1731606A1 Method of evaluating drug-sensitivity by analyzing mu-opioid receptor gene |
| 12/13/2006 | EP1731605A1 Cancer antigen peptides derived from wt1 |
| 12/13/2006 | EP1731604A1 Process for producing 1,3-propanediol and/or 3-hydroxypropionic acid |
| 12/13/2006 | EP1731603A1 Probes for detecting protein nuclear migration and method of detecting and quantifying protein nuclear migration using the same |
| 12/13/2006 | EP1731602A1 Pharmaceutical composition for lowering blood sugar level |
| 12/13/2006 | EP1731601A1 INACTIVE Ca2+/CALMODULIN-DEPENDENT PROTEIN KINASE II alpha KNOCKIN ANIMAL AND KNOCKIN CELL OF THE SAME |
| 12/13/2006 | EP1731599A1 Method of constructing recombinant herpes simplex virus |
| 12/13/2006 | EP1731531A2 Multiple cytokine-antibody complexes |
| 12/13/2006 | EP1731530A1 A kind of fusion protein, gene encoding it, expression method and use thereof |
| 12/13/2006 | EP1731529A1 Calcium ion leakage inhibitors |
| 12/13/2006 | EP1731525A1 Nucleotide derivatives and dna microarray |
| 12/13/2006 | EP1731171A1 Preventive/remedy for respiratory diseases |
| 12/13/2006 | EP1731166A2 Streptococcus pneumoniae proteins and vaccines |
| 12/13/2006 | EP1731164A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 12/13/2006 | EP1731155A2 Beta-D-2', 3' -Didehydro-2',3' -Dideoxy-5-Fluorocydine for use in the treatment of HIV infections |
| 12/13/2006 | EP1731144A1 Identification of genes altered in multiple myeloma |
| 12/13/2006 | EP1731032A1 Nonhuman animals for antibody production, and methods and systems for producing antibodies using such animals |
| 12/13/2006 | EP1731031A1 Transgenic fish with increased unsaturated fatty acid content |
| 12/13/2006 | EP1730534A2 Compositions and methods for treating lung cancer |
| 12/13/2006 | EP1730533A1 Adam8 as tumor marker and therapeutic target for non-small cell lung cancer |
| 12/13/2006 | EP1730313A1 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents |
| 12/13/2006 | EP1730309A2 Compositions and methods for optimizing cleavage of rna by rnase h |
| 12/13/2006 | EP1730300A2 Nitrile hydratases from metagenome libraries |
| 12/13/2006 | EP1730297A1 Method for screening agents modulating a lkb alpha protein ubiquitination and means for carrying out said method |
| 12/13/2006 | EP1730293A2 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast |
| 12/13/2006 | EP1730290A2 Compositions and methods for biodegradable polymer-peptide mediated transfection |
| 12/13/2006 | EP1730289A2 Method and products for the selective degradation of proteins |
| 12/13/2006 | EP1730288A1 Methods for transfecting natural killer cells |
| 12/13/2006 | EP1730287A1 Inducible promoters |